DERM
NASDAQ · Pharmaceuticals
Journey Medical Corp
$7.31
-0.05 (-0.68%)
Open$7.31
Previous Close$7.36
Day High$7.61
Day Low$7.29
52W High$9.56
52W Low$4.31
Volume—
Avg Volume141.6K
Market Cap205.76M
P/E Ratio—
EPS$-0.23
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+114.2% upside
Current
$7.31
$7.31
Target
$15.66
$15.66
$10.95
$15.66 avg
$21.05
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 70.49M | 74.72M | 106.46M |
| Net Income | -13,026,549 | -12,427,278 | 19.04M |
| Profit Margin | -18.5% | -17.6% | 17.9% |
| EBITDA | -4,461,300 | -4,492,511 | 19.03M |
| Free Cash Flow | — | — | 11.82M |
| Rev Growth | -5.7% | -5.7% | +23.5% |
| Debt/Equity | 0.79 | 0.79 | 0.74 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |